Medical expenditures for community-acquired pneumococcal disease in Japan

DOI Web Site
  • FUKUDA Haruhisa
    Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences
  • ONIZUKA Hiroaki
    Department of Interdisciplinary Science and Innovation, Kyushu University School of Interdisciplinary Science and Innovation
  • MURATA Fumiko
    Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences

Bibliographic Information

Other Title
  • 日本における市中肺炎球菌感染症による医療費
Published
2022-02-28
DOI
  • 10.20683/jniph.71.1_87
Publisher
National Institute of Public Health

Search this article

Description

<p>Objectives: The decision-making process for vaccination programs must be informed by cost-effectiveness analyses. This study was performed to quantify the medical expenditures for pneumococcal disease (PD) in Japan.</p><p>Methods: Surveillance data from the Japan Nosocomial Infections Surveillance program and insurance claims data were collected from community-acquired PD patients admitted to 29 hospitals in Japan. Patients with positive blood specimens were designated as having invasive PD (IPD). We estimated the medical expenditures incurred during the PD hospitalization episodes.</p><p>Results: The study sample comprised 1,358 PD patients from 28 hospitals between April 2015 and September 2017. Of these, 69 were IPD patients and 1,289 were non-IPD patients. The mean medical expenditures (standard deviation) for all PD patients, IPD patients, and non-IPD patients were estimated to be $6,610 ($13,133), $13,975 ($16,415), and $6,216 ($12,823), respectively.</p><p>Conclusion: This study is the first to quantify the medical expenditures for community-acquired PD in Japan.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top